Empirico
Alison Thomson is a Bioinformatics Scientist at Empirico Inc., with experience in antibody discovery and drug development. Prior to their current role, Alison worked at Biogen and Elstar Therapeutics Inc. as an Associate Scientist and Research Associate in antibody discovery, respectively. Alison also interned at various companies, including Visterra Inc., Dartmouth-Hitchcock, and SOPAT GmbH, gaining experience in drug discovery, cytogenetics, and particle size analysis. Alison holds a Master's degree in Bioinformatics from Northeastern University, where Alison also obtained their Bachelor's degree in Biochemistry.
This person is not in any teams
Empirico
1 followers
Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery and siRCH™ for the discovery and development of siRNA medicines - are used separately and in tandem to enable Empirico and our collaborators from the discovery and validation of novel targets to the development of clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs. Empirico is headquartered in San Diego, CA with a major second site in Madison, WI.